Risk Management and Healthcare Policy
Volume 13, 2020 - Issue
Review
Moving Towards Optimized Noncommunicable Disease Management in the ASEAN Region: Recommendations from a Review and Multidisciplinary Expert Panel
Nina T Castillo-Carandang1 Department of Clinical Epidemiology, College of Medicine, University of the Philippines Manila, Manila, Philippines; and Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines Manila, Manila, PhilippinesCorrespondence[email protected]
https://orcid.org/0000-0001-5360-1801View further author information
https://orcid.org/0000-0001-5360-1801View further author information, , Yook-Chin Chia3 Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Selangor, Malaysiahttps://orcid.org/0000-0003-1995-0359View further author information
https://orcid.org/0000-0003-1995-0359View further author information, Dung Do Van4 The University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnamhttps://orcid.org/0000-0001-6872-3481View further author information
https://orcid.org/0000-0001-6872-3481View further author information, Cheng Lee5 National Addictions Management Service, Institute of Mental Health, Singaporehttps://orcid.org/0000-0002-1116-4364View further author information
https://orcid.org/0000-0002-1116-4364View further author information, Ngoc Long Duong6 Department of Research, Education and Technology, Vietnam National Heart Institute, Hanoi, Vietnamhttps://orcid.org/0000-0001-9729-2262View further author information
https://orcid.org/0000-0001-9729-2262View further author information, Chee H Ng7 Department of Psychiatry, The Melbourne Clinic and St Vincent’s Hospital, University of Melbourne, Richmond, VIC, Australiahttps://orcid.org/0000-0002-3811-2732View further author information
https://orcid.org/0000-0002-3811-2732View further author information, , Anwar Santoso9 Department of Cardiology, Vascular Medicine, National Cardiovascular Centre - Harapan Kita Hospital, Universitas Indonesia, Jakarta, Indonesiahttps://orcid.org/0000-0001-8247-4151View further author information
https://orcid.org/0000-0001-8247-4151View further author information, Helen S Sigua10 University of the Philippines Open University, Laguna, Philippineshttps://orcid.org/0000-0003-3257-1054View further author information
https://orcid.org/0000-0003-3257-1054View further author information, Apichard Sukonthasarn11 Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailandhttps://orcid.org/0000-0001-7569-9563View further author information
https://orcid.org/0000-0001-7569-9563View further author information, , , , Grace E Brizuela15 Research, Development and Medical, Pfizer Upjohn, Manila, Philippineshttps://orcid.org/0000-0002-6093-8776View further author information
https://orcid.org/0000-0002-6093-8776View further author information, , Mathew Thomas17 Corporate Affairs, Pfizer Upjohn, Singaporehttps://orcid.org/0000-0002-1086-262XView further author information
https://orcid.org/0000-0002-1086-262XView further author information & show all